High Pressure Contrast Media Injectors Market
Number of pages: 100 | Report Format: PDF | Published date: April 17, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 124.1 million |
|
Market Size Value in 2031 |
US$ 406.9 million |
|
CAGR |
11.4% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Type, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global high pressure contrast media injectors market was valued at US$ 124.1 million in 2022 and is expected to register a revenue CAGR of 11.4% to reach US$ 406.9 million by 2031.
High Pressure Contrast Media Injectors Market Fundamentals
High pressure contrast media injectors (HPCMI) are medical devices used in diagnostic and interventional procedures that require contrast media. Contrast media are substances injected into the patient’s body to enhance the visibility of organs, tissues, and blood vessels during imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography. HPCMI are designed to deliver contrast media at high flow rates and volumes, at pressures higher than the physiological pressure of the patient’s circulatory system. This is necessary to overcome the resistance offered by the tissue and organ systems and ensure that the contrast media is promptly and efficiently delivered to the target area promptly and efficiently. HPCMI consists of an injector system connected to a contrast media source and a delivery mechanism that allows the contrast media to be injected into the patient’s body at a controlled rate and pressure.
[56756]
High Pressure Contrast Media Injectors Market Dynamics
The rising incidence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders is the primary driver for the revenue growth of global high pressure contrast media injectors. These injectors are widely used in diagnostic imaging procedures to visualize the internal organs and tissues of the body. For instance, according to the WHO’s September 2021 factsheet, cardiovascular disease is one of the leading causes of death, which caused around 17.9 million deaths in 2019. The increasing adoption of advanced imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) has led to a significant increase in the demand for high pressure contrast media injectors. These injectors are essential in enhancing the image quality of these imaging modalities. The rising demand for minimally invasive procedures has also fueled the revenue growth of the global high pressure contrast media injectors market. These injectors are widely used in minimally invasive procedures such as angioplasty and embolization.
However, the high cost of high pressure contrast media injectors can be a significant restraint on the market revenue. These injectors are expensive, and the high cost may limit their adoption, especially in developing countries with limited healthcare budgets. Moreover, high pressure contrast media can lead to side effects such as allergic reactions, nephropathy, and other adverse events. These side effects may limit the adoption of high-pressure contrast media injectors, especially in patients with a high risk of adverse events. Additionally, alternative imaging modalities, privacy concerns, and a lack of skilled professionals are some restraints impeding the overall high pressure contrast media injectors market revenue growth.
High Pressure Contrast Media Injectors Market Ecosystem
The global high pressure contrast media injectors market is analyzed from five perspectives: product, type, application, end-user, and region.
High Pressure Contrast Media Injectors Market by Product
[643634]
Based on the product, the global high pressure contrast media injectors market is segmented into consumables and injector systems.
The consumables segment dominated the market with the principal revenue share in 2022, attributed to its high level of safety. The consumables include various disposable items that are used in the injector systems. These consumables are essential components of the injector systems, and their demand is directly linked to the use of the injectors in diagnostic imaging procedures. Some common consumables used in high pressure contrast media injectors include syringes, tubing, and others. Syringes are disposable components that hold and dispense contrast media into the injector system. They come in different sizes and capacities to match the needs of varying imaging procedures. Tubing is used to connect the injector system to the patient’s intravenous (IV) line. The tubing is disposable and needs to be changed after each use to prevent the risk of infection. These factors contribute to the growth of the consumables segment’s revenue share.
The injector systems segment dominated the market with the second largest revenue share in 2022 because of its potential to be used in a large number of patients. The injector system includes the equipment to deliver contrast media into the patient’s bloodstream. These injector systems are essential to the diagnostic imaging process and are used in various imaging modalities such as CT, MRI, and angiography.
High Pressure Contrast Media Injectors Market by Type
Based on the type, the global high pressure contrast media injectors market is segmented into syringeless injectors, single-head injectors, and dual-head injectors.
The single-head injectors segment dominated the market with the principal revenue share in 2022. Single-head injectors refer to the type of injector system with one head for controlled contrast media delivery. These systems are used primarily in MRI imaging procedures, where precise control of contrast media delivery is critical for image accuracy. Single-head injector systems are designed to deliver contrast media at a controlled rate and volume to ensure uniform contrast enhancement in the imaged area. They are typically equipped with features such as automatic injection timing, flow rate control, and pressure monitoring to ensure the safety and efficacy of the procedure. These factors contribute to the growth of the single-head injectors segment’s revenue share.
The dual-head injectors segment dominated the market with the second-largest revenue share in 2022, attributed to speedier operations and regulated distribution benefits. The dual-head injector system has two separate injector heads for delivering contrast media at different rates and volumes. These systems are primarily used in CT imaging procedures, where precise control of contrast media delivery is critical for image accuracy. Dual-head injector systems are designed to deliver contrast media at different rates and volumes to different regions of the body being imaged. They are also equipped with features such as pressure monitoring, automatic injection timing, and flow rate control. These factors are attributed to the growth of the dual-head injector segment’s large revenue share.
High Pressure Contrast Media Injectors Market by Application
Based on the application, the global high pressure contrast media injectors market is segmented into endovascular surgery, interventional cardiology, interventional radiology, and others.
The interventional cardiology segment dominated the market with the largest revenue share in 2022, owing to the introduction of new and advanced high-pressure injector systems that offer improved safety, accuracy, and ease of use. The high-pressure injector systems are used in various cardiac imaging and interventional procedures such as angiography, cardiac catheterization, and electrophysiology studies. These procedures require the delivery of contrast media at high flow rates and volumes to visualize the blood vessels and the heart’s anatomy in real time. High-pressure injector systems used in interventional cardiology are designed to deliver contrast media at high pressures to overcome the resistance offered by the cardiovascular system. These overall factors contribute to the growth of the interventional cardiology segment’s sizable revenue share.
Similarly, the interventional radiology segment also accounted for a significant revenue share in the global market. The high pressure contrast media injectors are used in various radiology procedures such as angiography, embolization, biopsy, and drainage. These procedures require the delivery of contrast media at high flow rates and volumes to visualize the blood vessels, organs, and tissues in real time.
High Pressure Contrast Media Injectors Market by End User
Based on the end user, the global high pressure contrast media injectors market is segmented into hospitals, diagnostic centers, and ambulatory surgical centers.
The hospital’s segment is a key player in the high pressure contrast media injectors market with the largest revenue share in 2022, owing to the increasing prevalence of cancer, cardiovascular diseases, and other chronic illnesses. Hospitals use high-pressure injector systems in hospitals for various imaging and interventional procedures such as CT scans, MRI scans, angiography, and cardiac catheterization.
High Pressure Contrast Media Injectors Market by Region
Based on region, the global high pressure contrast media injectors market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global high pressure contrast media injectors market with the largest revenue share in 2022, attributed to the fast adoption of new technology, improved healthcare facilities, powerful consumer demand, and a just reimbursement system. Additionally, companies across the region are continuously involved in partnerships, mergers, and acquisitions, which is expected to improve the high-pressure contrast media injectors market outlook.
For instance, Bracco Diagnostics Inc., a U.S. subsidiary of Bracco Imaging S.p.A., received approval from the U.S. Food and Drug Administration (FDA) for importing Iomeron (iomeprol injection) into the United States. This approval has been granted in response to the ongoing shortage of iodinated contrast media. Iomeron (iomeprol injection) is a nonionic iodinated contrast medium that is suitable for use in adults for intravascular imaging procedures. Although it is currently registered in over 50 countries in Europe and Asia, it has not yet been approved for use in the United States.
High Pressure Contrast Media Injectors Market Competitive Landscape
The prominent players operating in the global high pressure contrast media injectors market are:
High Pressure Contrast Media Injectors Market Strategic Developments
The global high pressure contrast media injectors market was valued at US$ 124.1 million in 2022.
High pressure contrast media injectors (HPCMI) are medical devices used in diagnostic and interventional procedures that require the use of contrast media.
The expected size of the global high pressure contrast media injectors market in 2031 is US$ 406.9 million.
The revenue CAGR of the high pressure contrast media injectors market during the forecast period is expected to be 11.4%.
Some prominent players operating in the global high pressure contrast media injectors market are Bracco Group, Sino Medical-Device Technology Co., Apollo RT Co. Ltd., ulrich GmbH & Co. KG, and NemotoKyorindo Co.
*Insights on financial performance are subject to the availability of information in the public domain